Align Technology (ALGN) concentration risks

Align Technology's disclosed concentration is a single product-segment exposure: Clear Aligner net revenues represented approximately 80% of worldwide net revenues for the year ended December 31, 2025. By disclosed size this is a high-share structural exposure — the company's financial results are overwhelmingly driven by one product category, and that concentration reflects a deliberate business model built around the clear aligner orthodontic market rather than an unintended portfolio drift. The structural character of this exposure means the key risk channels are sector-wide rather than counterparty-specific: adoption trends among orthodontists and general dentists, competitive pressure from other aligner manufacturers, patient-level affordability and insurance coverage, and the pace of orthodontic case starts in the company's key geographies. None of these factors is a named customer or supplier whose relationship could be renegotiated, but all of them can move the segment's revenue trajectory in ways that have an outsized effect on total company results. Because this is the only disclosed concentration, there are no additional customer, geographic, or supplier dependencies layered on top of it in the filing. The profile is therefore straightforward: a predominantly single-product business where the entire top line rises and falls with the performance of the Clear Aligner segment. Monitoring procedure volume growth, average selling prices, and competitive share dynamics in the aligner market is the most relevant framework for tracking how this structural concentration evolves over time.

For the engine’s reasoning on ALGN’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.